These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

264 related articles for article (PubMed ID: 14517745)

  • 1. Developmental hemostasis: pro- and anticoagulant systems during childhood.
    Kuhle S; Male C; Mitchell L
    Semin Thromb Hemost; 2003 Aug; 29(4):329-38. PubMed ID: 14517745
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Developmental hemostasis: relevance to hemostatic problems during childhood.
    Andrew M
    Semin Thromb Hemost; 1995; 21(4):341-56. PubMed ID: 8747697
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Coagulation testing in pediatric patients: the young are not just miniature adults.
    Lippi G; Franchini M; Montagnana M; Guidi GC
    Semin Thromb Hemost; 2007 Nov; 33(8):816-20. PubMed ID: 18175287
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Assessment of the hemostatic system in healthy preterm and fullterm newborns].
    Pinacho A; Páramo JA
    Rev Med Univ Navarra; 1993; 38(2):23-30. PubMed ID: 14735720
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The coagulation system in children: developmental and pathophysiological considerations.
    Ignjatovic V; Mertyn E; Monagle P
    Semin Thromb Hemost; 2011 Oct; 37(7):723-9. PubMed ID: 22187394
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hemostasis in neonates and children: pitfalls and dilemmas.
    Monagle P; Ignjatovic V; Savoia H
    Blood Rev; 2010 Mar; 24(2):63-8. PubMed ID: 20074839
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The influence of developmental haemostasis on the laboratory diagnosis and management of haemostatic disorders during infancy and childhood.
    Male C; Johnston M; Sparling C; Brooker L; Andrew M; Massicotte P
    Clin Lab Med; 1999 Mar; 19(1):39-69. PubMed ID: 10403074
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The role of procoagulants and anticoagulants in the development of venous thromboembolism.
    Bertina RM
    Thromb Res; 2009; 123 Suppl 4():S41-5. PubMed ID: 19303503
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Developmental hemostasis: clinical implications from the fetus to the adolescent.
    Jaffray J; Young G
    Pediatr Clin North Am; 2013 Dec; 60(6):1407-17. PubMed ID: 24237979
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Anticoagulation therapy in children.
    Revel-Vilk S; Chan AK
    Semin Thromb Hemost; 2003 Aug; 29(4):425-32. PubMed ID: 14517754
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Principles of hemostasis in children: models and maturation.
    Guzzetta NA; Miller BE
    Paediatr Anaesth; 2011 Jan; 21(1):3-9. PubMed ID: 20849450
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Developmental hemostasis: laboratory and clinical implications.
    Toulon P
    Int J Lab Hematol; 2016 May; 38 Suppl 1():66-77. PubMed ID: 27426861
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evaluation of the coagulation system in children with two-ventricle congenital heart disease.
    Odegard KC; Zurakowski D; Hornykewycz S; DiNardo JA; Castro RA; Neufeld EJ; Laussen PC
    Ann Thorac Surg; 2007 May; 83(5):1797-803. PubMed ID: 17462402
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The relevance of developmental hemostasis to hemorrhagic disorders of newborns.
    Andrew M
    Semin Perinatol; 1997 Feb; 21(1):70-85. PubMed ID: 9190036
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Reference values for kaolin-activated thromboelastography in healthy children.
    Chan KL; Summerhayes RG; Ignjatovic V; Horton SB; Monagle PT
    Anesth Analg; 2007 Dec; 105(6):1610-3, table of contents. PubMed ID: 18042858
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hemostasis as an optimal system.
    Tyurin KV; Khanin MA
    Math Biosci; 2006 Dec; 204(2):167-84. PubMed ID: 17070559
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Developmental hemostasis: age-specific differences in the levels of hemostatic proteins.
    Attard C; van der Straaten T; Karlaftis V; Monagle P; Ignjatovic V
    J Thromb Haemost; 2013 Oct; 11(10):1850-4. PubMed ID: 23927605
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Age dependency for coagulation parameters in paediatric populations. Results of a multicentre study aimed at defining the age-specific reference ranges.
    Toulon P; Berruyer M; Brionne-François M; Grand F; Lasne D; Telion C; Arcizet J; Giacomello R; De Pooter N
    Thromb Haemost; 2016 Jul; 116(1):9-16. PubMed ID: 26988943
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Shock-induced alterations in hemostasis.
    Heene DL; Kirschstein W; Dempfle CE
    Klin Wochenschr; 1986; 64 Suppl 7():14-7. PubMed ID: 3560775
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Anticoagulant therapy of hemostatic disorders in suppurative septic diseases in children].
    Misharev OS; Dmitriev VV
    Vestn Khir Im I I Grek; 1982 Oct; 129(10):130-4. PubMed ID: 7179657
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.